ABModel view — historical tendencies for the days ahead, not a forecast
Next 1 day
-0.4%
Next 1 week
+3.4%
Next 1 month
+6.7%
Mean reversion
Deeply overbought — RSI(2) at 96
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought.
Its dip-buy edge in history is -0.37%/day.
Mean-reversion stats →
1-month breakdown —
Market · β 2.57 +6.7%
$59M/day volume
85% volatility
+136% 1-year
-81% from ATH
52-week range · 89% of the way up · -9% from the high
$2.74$15.02
Earnings Full history →
Next report 2026-11-09 (Monday, after close, in 11 days) · EPS est. -0.18.
1-day std dev
9.9%
Finished up
35%
Biggest pop
+20.1%
Biggest drop
-13.9%
Standard deviation of the close-to-close move over the last 23 reports. History, not a forecast.
| Reported | Est. | Actual | Surprise | Gap | Day 1 | Day 5 | |
|---|---|---|---|---|---|---|---|
| 2026-08-05 | miss | -0.16 | -0.18 | -9.1% | -2.2% | +10.3% | +85.3% |
| 2026-05-11 | beat | -0.20 | -0.14 | +29.1% | -9.3% | -5.7% | -22.9% |
| 2026-02-24 | beat | -0.18 | -0.03 | +83.3% | +4.3% | -0.9% | +12.7% |
| 2025-11-06 | miss | -0.16 | -0.19 | -17.3% | -16.1% | -13.7% | -18.5% |
| 2025-08-07 | beat | -0.16 | -0.12 | +26.5% | +13.7% | +0.2% | +8.3% |
| 2025-05-08 | miss | -0.14 | -0.15 | -5.3% | +2.5% | +1.0% | +1.0% |
| 2025-02-27 | beat | -0.15 | -0.12 | +20.8% | -6.8% | -11.5% | -20.2% |
| 2024-11-04 | miss | -0.13 | -0.17 | -30.8% | -13.5% | -5.9% | +2.4% |
| 2024-08-06 | beat | -0.14 | -0.13 | +9.3% | -3.5% | -7.7% | -8.1% |
| 2024-05-07 | beat | -0.16 | -0.14 | +13.3% | +0.0% | -5.0% | -8.4% |
| 2024-02-20 | miss | -0.12 | -0.16 | -33.3% | -1.1% | -9.4% | -4.3% |
| 2023-11-02 | beat | -0.13 | -0.10 | +22.2% | -10.4% | +6.1% | -8.8% |
| 2023-08-03 | beat | -0.12 | -0.11 | +10.8% | -6.5% | -13.3% | -17.4% |
| 2023-05-04 | miss | -0.13 | -0.14 | -6.1% | -3.0% | -9.4% | -13.2% |
| 2023-02-21 | miss | -0.01 | -0.10 | -900.0% | -2.1% | -1.1% | -8.3% |
| 2022-11-08 | beat | 0.05 | 0.08 | +77.8% | +6.1% | -3.5% | +18.6% |
| 2022-08-09 | miss | — | -0.02 | -400.0% | -3.5% | +20.1% | +17.1% |
| 2022-05-10 | beat | 0.42 | 0.54 | +29.3% | +4.8% | -13.9% | +20.9% |
| 2022-02-24 | beat | 0.18 | 0.19 | +8.6% | +10.8% | +5.7% | +0.9% |
| 2021-11-09 | miss | -0.06 | -0.08 | -41.2% | -8.0% | -3.9% | +0.7% |
| 2021-08-12 | miss | 0.09 | -0.01 | -110.7% | -1.3% | +17.8% | +5.6% |
| 2021-05-13 | miss | 0.38 | 0.37 | -3.5% | -7.0% | -7.0% | -6.2% |
| 2021-03-29 | miss | 0.81 | 0.37 | -54.3% | +18.2% | +14.6% | +34.3% |
Posted about ABCL
See all ›
Apes Alpha
neutral
—
Sun, 04 Oct
The Apes community has shown interest in ABCL -- AbCellera Biologics. Here's what we see. 1) Shortly after earnings there was a huge move due to…
TRACKER - Insider Clusters
long
11.30
Mon, 17 Aug
2 different insiders at AbCellera Biologics Inc. bought ABCL stock in the last 30 days — $864,937 between them, at prices they each paid separately.…
Not investment advice.
Continue with Google
👍
Thank you
👍🏻
Have not looked into that one at all tbh.
Seems to be picking up steam in the past week or so…
Any thoughts on $NAUT? (Another bio stock)
Yes, you’re correct phase 2 data results
I think that gap was caused by the trial result information. I would be very surprised if that gap filled a significant amount.
Yes that gap
You mean the big gap between 7 and 9?
Seems like it’s tired and may want to take a breather…?
@apes alpha; Gap fill potentially on $ABCL…? What do you think?